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ABSTRACT OF THE THESIS
Towards Extracting Protein-Compound Interactions from BioChemical Patents
by
Kaiser Stefan Pister
Master of Science in Computer Science
University of California San Diego, 2019
Professor Leon Bergen, Chair
We present in this work a protein entity tagging and normalization process focused on
data extraction from biochemical patents. The project acts a single stage in the pipeline of
general chemical interaction extraction. Novel to this work is the character embedded approach
to mention identification and normalization. Additionally, this is the first work to use a siamese
network and a prototypical network to augment protein database normalization. Our results show
that character embeddings provide a reasonable approach to protein entity extraction achieving
up to 6% better results than previous work, and that normalization tasks can be improved
significantly with a learned embedded space.
viii
Introduction
Biochemical patents are arduous to read and comprehend. They can require multiple
domain experts to parse out important details such as which proteins bind to what compounds
in what ways. With recent advances in information retrieval and semantic analysis from neural
networks, this project aims to reduce the workload on researchers in the field by performing parts
of these tasks automatically. In this work we focus on patent protein extraction and further divide
the task into three distinct subsections: protein entity recognition, protein mention normalization,
and target protein selection.
Protein entity recognition is a specific form of named entity recognition. Here we locate
all mentions of proteins within a document. To solve this problem, we build an LSTM classifier
which distinguishes protein from non-protein sequences.
Tagging proteins is only a piece of the puzzle. Protein mentions are often not consistently
referenced, leading to difficulty in finding related database entries. Thus, protein mention
normalization is the process of converting a protein mention into a standardized name. We
propose the use of deep learning to build embedded spaces which cluster mentions based on
similarity.
Patents often mention many proteins, but are only concerned with the effects of one or
two specific target proteins. We define the target protein selection task as recognizing which
normalized protein or proteins are of highest significance to the patent. We use a set of heuristics
combined with confidence scores from recognition to find the most important proteins.
This work presents a single pipeline to combine protein recognition, normalization, and
selection into a usable process for researchers to quickly analyze and extract information from
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patents without needing to delve too deeply into the dense writing itself.
2
Chapter 1
Background
In this chapter we describe various approaches that have been used in the past, analyzing
their effectiveness and describing ideas on which the rest of this work is based. We concede that
this is by no means an exhaustive list of works in the area, as that list would be too large to fit
into this short paper.
Mention Recognition
There are many different obstacles in the way of recognizing a protein in biochemical
documents. Primarily, the density of information can be daunting. Patents are packed with jargon
which can be easily confused for important biochemical information. Without years of study and
domain experience it would be impossible for a human to pull out the most important entities.
As a result, researchers look to approaches which quickly learn in ways that humans cannot. In
pursuit of protein entity recognition many groups have used traditional algorithms to varying
degrees of success [8] [13]. These approaches often consist of regular expression- and rule-based
dictionary lookups. In recent years, these approaches have been pushed out of practice and out
performed by new techniques in deep learning [23]. We leave the discussion of these traditional
methods to normalization where they are still comparable in performance.
In pursuit of well performing cheminformatics processing, BioCreative hosts competitive
research workshops on a regular basis [10]. These workshops focus on specific tasks, such
as chemical entity recognition, relationship extraction, document triage, and more, prompting
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researchers to apply modern techniques to solve problems in the field of chemistry and biology.
In the most recent two workshops, all of the top performing models leveraged advances in neural
networks [11] [12].
The majority of work in this problem space make use of long short term memory neural
networks which have proven to be quite effective in solving natural language processing tasks
due to their ability to processes sequential data, extracting information from surrounding context.
Since it has been discussed in great detail elsewhere, and the internal structure of an LSTM cell
does not play a key role in this work’s innovation, we refer the reader to [26] for a complete
description of the mathematics behind these models.
Using LSTM architectures, research groups have been able to achieve great performance
on chemical entity recognition [17]. However, the general task of tagging chemical entities
proves to be easier to learn than tagging specifically proteins. At BioCreative V.5, the best teams
achieved F1-scores above 90% when classifying chemical entities, while the GPRO (gene protein
related object) tagging scores lagged behind at 81% [11]. General chemical entities often follow
a stricter naming scheme than proteins, resulting in stronger patterns and signals which a network
can identify [29].
Many deep learning approaches to recognition look fairly similar. Previous works largely
build their neural network architecture from a set of LSTM nodes and a feature set from some
combination of word embeddings and document information (e.g. frequency count or location in
sentence) [8] [14] [20] [23]. These approaches have outdone previous results, however they also
suffer from a couple of different problems. Due to the limits of manual annotation, the input data
on protein names and feature sets of frequency, location, etc. are not necessarily representative of
the full dataset [14]. Word embeddings do not convey the same information about form through
the network, losing information about casing and structure of the sequence, forcing these to be
used as separate features, leading to larger parameter spaces and more complicated networks
[16].
Less common, character embedded models are another approach. In most work, they
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Figure 1.1. The structure of a character embedded bi directional LSTM neural network. Image
from: [21]
manifest as a single feature of input data to be processed alongside a word embedding [23] [28].
We argue that the character model alone is enough to perform recognition, as has been shown in
other application spaces [21]. In the work of Ling et al., they show that the form of a word can
often convey enough information for classification tasks. These models rely on a non-arbitrary
connection between the form and function of a sequence. The form of a character embedded
model is shown in figure 1.2, which makes use of a character embedding flowing through a
bi-directional LSTM network [21].
Some attempts at different architectures have been used in the past, a common thought is
to use character embedded convolutional neural networks, however these approaches have not
historically performed as well due to the importance of order in the sequence. In contrast, LSTM
RNN architectures carry information directly through the order of the sequence [14].
The most common method of classification follows the BIEO system, tagging tokens as
the Beginning, Internal, Ending, or Outside of a sequence [27]. Some approaches extend this
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with a Singleton class as well to denote a single token sequence. Documents will be tokenized,
often splitting into sentences, and then word sequences based on spaces, punctuation or special
characters [13]. Depending on its location in a protein sequence, each token will then be tagged
according to the BIEO scheme. Due to abnormal structure of chemical jargon, tokenization is
not as simple a task as on traditional documents, preventing automatic solutions [5]. The result is
that BIEO systems often have a smaller input dataset to train on, since the only reliable data will
be hand curated. In trade for the smaller dataset, the BIEO system allows for precise learning of
sequence structure that a binary system would not.
Mention Normalization
Due to its importance in database curation, named entity normalization is a heavily
researched problem [22]. The most common approach has been dictionary look-up [5]. These
normalization techniques range from a naive edit distance comparison between a target and
the dictionary, and more complex regular expression comparisons. An alternative to dictionary
look-up is rule based normalization, which describes a set of functions that transform the mention
into a standardized form and then often use the standard form to perform dictionary look-up.
A list of common problems in normalization are shown in table 1.1 [27].
Perhaps the most commonly discussed disadvantage is that dictionary based approaches
miss 100% of all new proteins. Without a constantly updating dictionary it is impossible to
determine what a new protein normalizes too. Word embedding approaches have this issue
as well, which we will discuss below. Stemming is a more difficult issue than commonly
seen in linguistic tasks, as biochemical entities do not follow the same naming conventions as
many normal stemming rules expect. The result is poorly stemmed names which cause more
confusion than help. Acronym expansion is an issue in many different approaches, but can
often be remedied by structural rules. For example, many documents will expand a full name of
an entity before writing its acronym in parenthesis, allowing for easy detection. Orthographic
variations account for a significant number of different representations of entities. Finally,
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Table 1.1. Issues with normalization of protein names
Protein Mention Standard Name Issue
GHF1 GHF-1 Orthographic var.
GHF-1 Growth Hormone Factor 1 Acronym
Transcriptional Factor Transcription Factor Stemming
Antimicrobial Peptide NDBP Naming var.
naming conventions vary across regions and institutions, leading to tens of different ways to
referring to the same protein. For a more in depth examination of normalization issues, we point
the reader to Eltyeb et al. [5].
Beyond all of these problems, an even more pressing issue arises as noted by Leaman et
al., which is that the process of name normalization often follows the imperfect process of entity
recognition [16]. The pipelined nature of this task leads to cascading errors which can make any
approach look worse than it would in an isolated case.
In 2010, BioCreative proposed a research track to normalize protein and gene names.
The results of the track were dismal, with TAP-k scores of under 0.45 (k=20) [22] (an equivalent
F1-score of 46.56% [27]). At the time, almost all approaches were constrained to either regular
expression- or rule-based dictionary retrieval, with only a couple submissions making use of
machine learning techniques such as conditional random fields, and support vector machines.
More recently, there have been approaches to perform normalization with deep learning ap-
proaches [15][16][27]. These approaches use embedded spaces to transform proteins or protein
representations into some new space, and then use a pairwise ranking function to find the nearest
neighbor.
All of these works are using pre-trained word embeddings, sometimes with feature sets
which include character representations. Since we build our features from only the character
embeddings of sequences, there are other avenues of normalization available to our approach.
In 2005, Chopra et al. proposed a new network architecture called a siamese network [1].
Figure ?? displays the structure of a siamese network. The purpose of this network is to build an
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Figure 1.2. The structure of a siamese network with convolutional encoders. Image from: [1].
embedded space on the input data by embedding the data and optimizing loss on a distance metric
between different classes of input data. The work was improved upon in [9]. In constructing this
embedded space on character embeddings of normalized proteins with some of their mentions,
we can find the nearest neighbor of an unknown embedded protein mention and treat that as the
normalized name. This method acts in a very similar way to clustering techniques. For distance
metrics, we use cosine similarity and Euclidean distance between points. The loss function is a
contrastive loss function.
Hard negative mining (HNM) gives better results in similarity prediction as it furthers
the distance between similar classes [7]. With HNM, the loss of each batch is penalized for
the distance between each positive pair of input, and the similarity between each input and the
closest non-identical element of the same batch. The result is that the network will build large
inter-class distance, while keeping intra-class distance small.
More recently, Snell et al. proposed Prototypical networks for the task of few-shot or
zero-shot classification [25] of handwritten characters. Prototypical networks aim to find the
prototype of a class which acts as the center of a cluster by averaging the embeddings of each
8
Figure 1.3. Predicting an input value X using few-shot and zero-shot prototypes. Image from:
[25].
member in a class. Shown in figure 1.3, the prototypes of each class are used to predict on input.
Then when embedding a new input with the network, their results show, the nearest prototype is
a more accurate predictor of the class. Their structure also follows a contrastive loss function
built on Euclidean distance. Building on their work, we apply a prototypical embedding network
to the normalization process and compare the results in chapter 3.
Relation Extraction
This work acts a stepping stone towards solving the larger problem of extracting re-
lationships between proteins and compounds in biochemical patents. We do not address the
relationship extraction task, though there has been other recent research on this task. At the
most recent BioCreative workshop, an entire track was dedicated to this problem [12]. Bert was
introduced in 2018 by Devlin et al. as a new approach to solve many different natural language
processing tasks. The key to its success is the idea of using a layer of transformers which perform
significantly better than previous state of the art [4]. Following Bert, Lee et al. propose a domain
specific BioBert which takes the same architecture but pre-trains with a different biology-tailored
dataset [18]. Using different input data gives the Bert model a strong contextual understanding
of biological terms which has given similarly impressive improvements to retrieval tasks in the
biochemical domain. Some other recent applications use transfer learning with specialized word
embeddings to extract relationships [3]. For more complete information, we refer the reader to
[23].
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Chapter 2
Methodology
In the following chapter, we describe the various approaches to solve each step of protein
extraction. We conclude with some unsuccessful methods and the knowledge gained from them.
As mentioned previously, we segment the task of protein extraction into three parts: protein
recognition, protein mention normalization, and target protein selection.
Protein Mentions Recognition
To recognize protein mentions in documents, we build a character embedded bidirectional
LSTM classifier. The model is inspired by Ling et. al’s work and does not innovate on their
structure. Our goal is to make use of character embedded models in the biochemical application
space, since previously most work focuses on word embedded models.
Dataset
We use a dataset of protein names gathered from the UNIPROT KB gold star database
[2]. This dataset includes information about each protein, from which we take the full name and
alternative names for each entry. This dataset includes 64,496 unique proteins and approximately
240,000 total names. There are almost twice that many entries in the database, however there are
duplicates for each species where the protein is found, which we do not include as the mentions
are the same. The full set of protein names is treated as our positive dataset. To generate a set of
negative sequences, we scrape bio-medical Wikipedia entries. We choose bio-medical pages to
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have a better contextual match to the content in patent data, hopefully negating generic scientific
terms while emphasizing proteins. With hundreds of pages as negative input, we have millions
of negative data points. As an additional negative dataset, we generate a blended set of data
which consists of fractions of protein names combined with parts of Wikipedia sequences. These
blended samples are randomly generated and are meant to help the classifier find the precise
location of a protein mention without including the surrounding words. We also include the
patents themselves as a negative dataset. This will train the model to dismiss common sequences
in the patents, while highlighting rarer sequences. Finally, we include a list of metabolites (small
chemical compounds) as a negative dataset. Metabolites represent the most common chemical
entities in our patent dataset, so we use them with a negative label to better target proteins.
With each dataset, we convert it into a set of uni-, bi-, and tri-gram sequences which
are then fed into the model with their respective labels. We restrict our labels to positive or
negative, ignoring the location of a token in a protein mention. We hypothesize this will improve
the network’s ability to reorder parts of proteins, however it comes at the cost of less precise
boundaries of mentions.
We also perform casing and ordering transformations on the positive dataset. The case
of a protein can convey distinctive information, but is not standardized across usage, thus we
allow for all forms of casing to be positive (e.g. Adenosine A1, adenosine A1, adenosine a1,
Adensosine a1). Additionally, we compute some permutations of the protein names to allow for
different usage (e.g. adenosine a1, a1 adenosine). With these transformations, we capture many
different styles of writing protein names.
Architecture and Parameters
The architecture of our model is a simple single layer bidirectional LSTM RNN. We use
a one hot character embedding model to convert each sequence to a network readable input, then
create a single hidden layer of 120 LSTM nodes which feed forward into a fully connected layer
that outputs to 2 classes. We use a ReLU non-linearity function on the results. To convert the
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LSTM layer to the fully connected layer, we average across all the hidden layer weights. Similar
to other work, we use a learning rate of 0.001 and an ADAM optimizer. The loss function is a
categorical cross-entropy loss. These parameters were chosen after performing a grid search
across layer size, learning rate, and batch size.
Normalizing Mentions
Protein mentions are notoriously diverse. As mentioned previously, they can be repre-
sented with abbreviations, in different term order, with different spellings, or simply different
colloquial names. Thus a single protein may be discussed with five, ten or even twenty different
possible descriptions. When we identify a single mention, we cannot assume that the form of
that mention is the normal form that will be stored in a dictionary. We solve this problem with
three methods and evaluate their effectiveness in the next chapter.
Dataset
We utilize the same positive dataset as the recognition step, but modify its structure to
distinguish classes of proteins. For each protein, we define the class name to be its Full Name
according to UNIPROT, and list every other version of its name as an example of the class. With
about 64,000 proteins, and 240,000 mentions, there are an average of 4 entries in each class,
ranging from a low of 1 entry to a high of 23. All the protein names are transformed to lower
case ASCII for simplification, which does lose some information on UTF-8 encoded characters.
Using the Python package unidecode, we convert any UTF-8 characters to their closest ASCII
approximation to minimize any differences. We divide our dataset two different ways. First
we build a zero-shot dataset, in which our training data will see 60% of the classes, and every
mention representing those classes. The other 40% is divided between validation and test sets.
This dataset is zero shot because the model will not have seen any elements of these classes and
therefore will have no prior on where to embed them. Then we build a few-shot dataset in which
we divide each class into a 75-25 training-test split based on mentions. We discard any classes
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that have fewer than 4 representations. This will train the model to embed based on parts of
classes, and evaluate the model on how well it learned to embed unseen mentions of seen classes.
Levenshtein Distance
Our first normalization method calculates the sequence edit distance between two input
strings using the Levenshtein distance metric [19]. This distance function attributes 1 point of
error for each deletion, insertion and substitution.
Siamese Embedding
Our major contribution to this space is our work in training embedded spaces for normal-
ization. As discussed in chapter 1, this is a widely studied field with many different application
spaces. As far as we are aware, this is the first application of these deep learning embedded
spaces to this problem. We again train a bidirectional LSTM RNN to encode protein mentions
which refer to the same protein class into similar locations. Our architecture is very simple, we
have a layer of 120 LSTM cells feeding into a fully connected layer which outputs into a 100
dimensional vector and then a ReLU function. The resulting vector is our embedding of the
input. The siamese network’s goal is to learn an embedding function such that two elements of
the same class (i.e. two mentions of the same protein) will be a small distance apart, while two
elements of different classes will be a large distance apart. The structure of our contrastive loss
function resembles previous work [1], but we tailor it to our task, training on multiple distance
functions as well as optimizing with hard negative mining techniques.
We train our model with both a Euclidean and a cosine similarity distance function and
evaluate their different performances. Cosine similarity provides simpler and more efficient
implementations, but can lead to poorer performances [25]. As is necessary for all cosine
similarity distance functions, when training we add more more length normalization step to all
embeddings.
Using hard negative mining, we target the poor performers of each batch to ensure that
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the network learns a robust embedding. When using Euclidean distance, we adjust the hardest
negative mining to be what we call harder negative mining. This is a stochastic approach in
which we sample a subset of the batch, and only find the hardest element of that subset. While
this will in practice potentially not create an optimal embedded space, the random nature of it
does well enough, and it significantly improves performance of training.
With each positive and negative example we use a contrastive loss function to improve
performance over time. Once we have an embedded space, we are able to find the nearest
neighbor of an protein mention sequence by running it through the network. If the network has
created a good embedding, then the mention will be close to the other proteins it relates to.
Prototypical Network Embedding
Another approach that we briefly explore to create an embedded space is following
the idea of [25], in which we create a prototype representation for each protein. Then, sim-
ilar to the siamese embedding, we can feed any sequence into the network and attempt to
find the closest prototype. This prototype will correspond to the normalized entry in the
database. We use the open source code accompanying the paper by Snell, accessible at
https://github.com/jakesnell/prototypical-networks, only changing the encoder to
follow suite with our other models, and adapting the dataloader to accept our dataset.
Target Protein Extraction
With the above architectures, we pass a patent document through a few preprocessing
steps and the recognition model to receive a list of probable protein sequences. Using the
DBSCAN clustering algorithm and a Euclidean distance fucntion over the embedded space
of our Siamese network, we cluster the probable sequences into groups of similar mentions
[6]. Then we weigh the clusters based on an average confidence score of its members and
output the best two clusters. We give extra weight to protein mentions in the title, abstract,
and reference sections as well as sections surrounding certain keywords which we identify as
14
often correlated with the target protein mention. Currently these sections surround the keywords
“patent,” “invention,” “receptor,” and “inhibitor.”
Other Explored Areas
Throughout this process, we encountered and explored a variety of other approaches
to solve the recognition problem. We find it important to document science in the presence of
failures to allow for the better distribution of ideas and to hopefully provide ideas and guidance
to others attempting to solve the same problem.
TF-IDF
Term Frequency Inverse Document Frequency can be a powerful metric in finding words
that are important in a document. The metric compares how many times a term appears in a
single document relative to the total number of times it appears in a corpora. Thus, a word that
shows up 5 times in a document, and only 5 times in the entire corpora (notably the same 5
appearances in the document we are testing), will have a TF-IDF score of 1.0. Inversely, a term
that is in a document 5 times, but appears 1000 times in the corpora (not uncommon for simple
words), will have a TF-IDF of 0.005. This approximation should give a score of how important a
term is to a given document. Here are some issues we found that occur with TF-IDF.
• The corpora isn’t large enough. This is the most common issue. Without a large set of
words to normalize out slightly uncommon terms, words like ”office” end up with very
high scores as they don’t commonly appear in the text. In the same vein, this issue causes
problems when documents are written by different people. We write very differently based
on geolocation and education and will use very different sets of vocabularies even within
the same language. We have 1515 patents, which is not enough to block out common
words.
• The proteins are rarely similarly mentioned. As discussed in the normalization section,
different groups might refer to the same protein in many ways, and even within the same
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document a protein will be mentioned in different ways. This problem is more general
to include the idea of non-stemmed words. An example is seeing the term ”word” and
”words” as different terms. There exist approaches to stem words, but this can often
cause problems with protein names. Additionally stemming is not a correct normalization
function for proteins, so that problem would persist regardless.
• The proteins are very infrequently mentioned. This might not actually be a problem if
the protein isn’t mentioned in any other documents, however proteins often share pieces
of terms. ”Kinase” for example is a very common suffix term of a protein name. This
leads to a very low score for any terms including ”Kinase” despite the definite importance.
Patents are often focused on the new compounds being invented and aren’t focused on the
proteins, as a side effect the proteins aren’t mentioned as much and might not be unique to
each document.
TF-IDF does provide some interesting insights into the problem but ultimately is not the
best approach. One thing we do consider for future work is an ensemble method including the
TF-IDF score for each term, however the above problems would need to be addressed before
that work would be conducted.
Convolutional Neural Networks
Another logical approach would be a CNN. Given we are already working with a character
based LSTM model, it is not too far a step to experiment with a CNN. This follows the from the
idea that our architectures work for any form of encoding method, however the results will find
some encoders to be better than others. For this reason we do conduct some early experiments,
however we found no significant differences from our LSTM model results, and continued efforts
in developing the LSTM model instead. We do concede that this could be further explored,
however as pointed out in [16], convolutional networks will suffer from lack of sequence ordering
details.
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Chapter 3
Results
We analyze our different models under the usual heuristics of precision, recall and f-
measure in order to assess their correctness. Both the recognition and normalization models are
evaluated individually. After we show a combined evaluation of how well they solve the protein
extraction task on a dataset of patents.
Recognizing Mentions
We compare our results here against other works on the BioCreative V & V.5 protein
tagging competition results. On the GPRO ChemDNER dataset, the best reported results were
an F1-score of 81.2%, with a best precision of 80% and a best recall of 85% on different runs
[13] [11]. These results were generated from various models ranging from CRF LSTMs to
dictionary look-ups. Using the same evaluation metric, our recognition model under performs in
comparison to state of the art. We are achieve an F1-score of 73.08% on the GPRO dataset.
Error Analysis
We find the strict nature of the evaluation to cause a significant number of errors in our
model. The recognizer would, for example, tag the sequence “human p55 TNF” as a single
protein sequence instead of two. This style of error, in which the model is off by a single word or
contains two proteins in one, account for more than 70% of the false positives in our predictions.
Below we perform a more in depth analysis of our model, allowing for these errors to
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Table 3.1. Results of Protein Entity Recognition
Evaluation Type Precision Recall F1-Score
Our Model 85.10% 89.05% 87.03%
Best Prior 83.95% 78.66% 78.7%
be treated as correct mentions, resulting in a significantly higher F-score. To reiterate the type
of error we allow, for the sentence ”We use human p55 TNF as an inhibitor of compound Z,”
the desired tagging would be proteins = {“human p55”,“TNF”}.Our tagger might produce
proteins= {“human p55TNF”,“p55TNF”,“TNF”}.With relaxed matching “p55 TNF” is not
considered a false positive and “human p55 TNF” satisfies the ”human p55” protein name. With
trigram sequences, we will never allow a relaxed match which is more than a single token in
distance away from truth. We could potentially reduce this problem by tagging with the BIOE
system. The results of these two evaluations are shown in table 3.1.
The results of best prior are from the BioCreative V.5 which evaluated the performance
of recognizing normalized and non-normalized protein and gene mentions in abstracts [24].
We evaluate our model by grabbing the matches which are above a 95% confidence score
of being a protein to reduce the number of false positives, at the cost of slightly larger amount
of false negatives. We make this choice because definitely having some proteins is much better
than having to sift through a lot of bad data.
As shown in the table, with relaxed matching, we are able to significantly improve upon
the results of previous work. Under strict matching, we have many more false positive mentions,
as shown in the example above where “p55 TNF” will be considered an erroneous tag causing a
significantly lower precision score. We perform a manual review of these false positives, finding
28/100 to be true false positives while 72/100 fall under the same situation of “p55 TNF” in
that they represent parts of true protein names. We find it more important to tag an approximate
location of a mention over the exact bounds of a protein so we accept the relaxed matching idea.
We acknowledge that other groups could potentially also improve their results when
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using the kind evaluation metric.
Normalizing Proteins
There have been fewer attempts at normalizing protein mentions. As such, we compare
against a couple other methods, and create a new baseline to evaluate our new models.
A New Baseline
The baseline we create is a binary test to check if two protein mentions refer to the same
protein or are different proteins. Due to the binary nature of the test, a random guesser would
perform an even 50%. We use a test dataset containing an even split of positive and negative
pairs. For each test we are optimizing for the highest quantity of correct results.
A naive approach to solving this baseline is to compare the Levenshtein distance between
the two input mentions against a threshold, returning true if the distance is small and false if it is
large. This approach has the advantage of catching small differences between protein mentions
from casing, reordering etc. It suffers on acronyms (since there is a large edit distance between
A1A and A1 Adenosine) and completely different mentions. We perform baseline tests at a range
of different threshold values, and also on a dataset without acronyms. With optimal parameters,
the approach achieves an accuracy of 64.34%. We also evaluate this approach on the dataset
without including any acronyms to better favor the metric, improving accuracy to 67.50%.
Table 3.2 shows common examples of errors when the Levenshtein distance metric fails
to evaluate similarity. When choosing a threshold, there must be a balance between allowing
enough distance between two similar proteins, while minimizing the false positives that will
show up as in the third row of the table. Additionally, as seen in the second row, some protein
mentions are sufficiently different that no linear distance metric would suffice.
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Table 3.2. Examples of Levenshtein Distance Metric Errors
Type Proteins Reason Distance
False Negative nlrr-4 Acronym 34
Leucine-rich repeat neuronal protein 4
False Negative NDBP-4.17 Different Name 27
Antimicrobial peptide UyCT3
False Positive f18 Too short 3
PAP
Siamese Network Performance
The first model we propose to solve this problem is a zero-shot siamese network archi-
tecture. As described in chapter 2, we use the siamese network to create an embedded space.
After embedding both input mentions, we compute the Euclidean distance between them and
compare that distance against a threshold. Similar to Levenshtein distance, we return true if the
distance is under the threshold and false otherwise. We range over many threshold values to
find the optimal threshold of 0.6. At the selected threshold, the siamese network significantly
outperforms the Levenshtein distance, achieving an accuracy of 79.05%.
The errors of the siamese network are less straightforward compared to the Levenshtein
model as it is not clear the model the network learned for the problem. The performance of this
network is evaluated on proteins for which it has seen none of the classes or mentions.
Notably these are zero-shot models. The network trains on an entirely separate dataset
from the test data, meaning it has seen no forms of each test protein.
We additionally train a few-shot siamese network in which we give some examples of
each protein class and mentions. Since each protein has many names, we define one name to be
the standard form, then split the remaining names into training and test. In evaluation we test
against the held out set of mentions which the network has not seen. Our best performance with
this network is 87.43% accuracy. We will use this as a classifier in the future.
It is important to note that all tests are run on valid data. We do not attempt to normalize
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Table 3.3. Normalization Task Results
Model Accuracy
Levenshtein 64.34%
Levenshtein (no acronyms) 67.50%
Euclidean siamese (zero-shot) 79.05%
Euclidean siamese (few-shot) 87.43%
Cosine Sim. siamese (zero-shot) 76.12%
Prototypical (zero-shot) 63.89
erroneously tagged sequences. This is in an attempt to evaluate the normalization processes
instead of the tagging process and not allow for cascading errors as talked about in [16].
Prototypical Network Performance
Finally we attempt to solve the zero-shot normalization task with a prototypical network.
On the same task the network does very poorly, getting at best 63.89% accuracy. In future work,
we would experiment more thoroughly on the parameter space of the network in attempts to
improve this score.
Targeted Protein Results
In order to evaluate the practical results of these models, we use them to predict the target
proteins of 200 patents. The patents were manually annotated with the set of import proteins
mentioned in that patent. Once we tag, normalize and cluster the proteins in each document, we
manually check these 200 patents for accuracy of the top clusters. We find that in 48% of the
patents, the top rated cluster contains one of the target proteins, while 25% more were contained
in the second highest weighted cluster. This level of extraction would still certainly require
human guidance, however it provides a starting point that would potentially help expedite the
processes for domain experts.
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Chapter 4
Conclusion and Future Work
Our performance in both recognition and normalization show that character based models
have a place in protein extraction. Using larger datasets than manually annotated abstracts gives
us a wide scope of learning material from which our normalization model does quite well. The
range of methods and applications covered in this project under the time constraints given lead to
a cursory exploration of many parts in the biochemical natural language processing space. There
are many parts of the project where we would look to improve or expand our work as described
in the following list:
1. Interaction Extraction With strong chemical compound extraction techniques, our pro-
tein extraction techniques and the semantic understanding ability of BioBert, we would
like to build a single pipeline for full relationship extraction. This would be a large task
that would greatly benefit documentation, triage, and exploration of new proteins and
protein relationships.
2. Prototypical Networks The classifier built on a prototypical network performs quite well
on the protein set, however it could be improved on the baseline. There is more work to
be done on fine tuning the parameter space as well as the encoding methodology of the
network.
3. Building a stronger pipeline By no means do we believe any part of this work to be the
final stage in the research of its field. Converting our pipeline into a modular work so that
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we could easily incorporate improvements from other protein recognition, normalization
or targeting steps would make the project more serviceable and usable by researchers.
4. De-noising Protein Mentions Using the same normalization techniques, we would like
to training a network to remove noise in erroneously tagged protein mentions. This would
help solve some of the protein recognition problems we encounter, converting “a TNF” to
“TNF.”
5. Morpheme embedded Networks There has been recent research into training networks
on the morphemes of words rather than the characters or full words themselves. We would
like to take this approach to protein names as well, since the morphemes in a name often
convey useful information.
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